Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription 07.11.2022 4 Arthritis Res Ther 1 Eur J Immunol 1 Intern Med 6 J Rheumatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arthritis Res Ther

1. BERGMAN M, Tundia N, Martin N, Suboticki JL, et al
   Correction: Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial.
   Arthritis Res Ther. 2022;24:248.
   PubMed        
   
   
2. YAO Y, Cai X, Zhang M, Zhang X, et al
   PSTPIP2 regulates synovial macrophages polarization and dynamics via ERbeta in the joint microenvironment.
   Arthritis Res Ther. 2022;24:247.
   PubMed         Abstract available
   
   
3. HEIN TR, Peterson L, Bartikoski BJ, Portes J, et al
   Response to Comment on "The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis".
   Arthritis Res Ther. 2022;24:246.
   PubMed        
   
   
4. MINAMINO H, Torii M, Katsushima M, Fujita Y, et al
   Comment on "The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis".
   Arthritis Res Ther. 2022;24:245.
   PubMed         Abstract available
   
   

   
   Eur J Immunol

5. WANG S, Zhou Y, Huang J, Li H, et al
   Advances in experimental models of rheumatoid arthritis.
   Eur J Immunol. 2022 Nov 3. doi: 10.1002/eji.202249962.
   PubMed         Abstract available
   
   

   
   Intern Med

6. MOCHIZUKI T, Yano K, Ikari K, Okazaki K, et al
   Factors Associated with Five-year Deterioration of the Health Assessment Questionnaire-Disability Index in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study.
   Intern Med. 2022 Nov 2. doi: 10.2169/internalmedicine.0651.
   PubMed         Abstract available
   
   

   
   J Rheumatol

7. DUMOULIN QA, Verstappen M, van der Helm van Mil AHM, van Steenbergen HW, et al
   Joint Damage Over Time in Patients With Early Rheumatoid Arthritis Follows Trajectories Related to Distinct Courses of Disease Activity.
   J Rheumatol. 2022 Nov 1. pii: jrheum.220531. doi: 10.3899/jrheum.220531.
   PubMed         Abstract available
   
   
8. LANGE A, Kostadinova L, Damjanovska S, Gad I, et al
   Red Cell Distribution Width and Absolute Lymphocyte Count Associate with Biomarkers of Inflammation and Subsequent Mortality in Rheumatoid Arthritis.
   J Rheumatol. 2022 Nov 1. pii: jrheum.211411. doi: 10.3899/jrheum.211411.
   PubMed         Abstract available
   
   
9. TAKANASHI S, Takeuchi T, Kaneko Y
   Impacts of ageing on rheumatoid factor and anti-cyclic citrullinated peptide antibody positivity in patients with rheumatoid arthritis.
   J Rheumatol. 2022 Nov 1. pii: jrheum.220526. doi: 10.3899/jrheum.220526.
   PubMed         Abstract available
   
   
10. SATTUI SE, Lieber SB
    Keep It in Mind: Assessing the Risk of Dementia in Patients With Rheumatoid Arthritis and Opportunities for Intervention.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220991. doi: 10.3899/jrheum.220991.
    PubMed         Abstract available
    
    
11. TAYLOR PC
    The Opportunities and Challenges of Telemedicine in the Management of People With Rheumatoid Arthritis.
    J Rheumatol. 2022;49:1188-1190.
    PubMed        
    
    
12. VENKATACHALAM S, Nowell WB
    Taking the Long View: Patients Perceive Benefits and Risks of Treatment as Multidimensional.
    J Rheumatol. 2022;49:971-973.
    PubMed        
    
    

    
    PLoS One

13. JUNG N, Park S, Kong T, Park H, et al
    LC-MS/MS-based serum proteomics reveals a distinctive signature in a rheumatoid arthritis mouse model after treatment with mesenchymal stem cells.
    PLoS One. 2022;17:e0277218.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: